Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.
Clinical trial NCT02387606 · COMPLETED
Trial details
- NCT number
- NCT02387606
- Sponsor
- Janssen Sciences Ireland UC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-07
- Primary completion
- 2015-09-21
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.